Solutions
Pricing
Log in
Teams
Get started
Log in
Get started
Untitled video
JK
by
Jessica Kindynis
·
2 views
·
Updated Nov 28, 2020
Share
Embed
Create your own
Audio Transcript
Auto-generated
00:00 - 00:01
hi there.
00:01 - 00:03
I hope you're excited to learn something new today.
00:03 - 00:06
In the landscape of medical cannabis for chronic pain, GPS
00:07 - 00:10
have reported a more than 65% increase in chronic pain
00:10 - 00:11
presentations in the past decade.
00:12 - 00:15
Given the health concerns and addiction risks associated with common
00:16 - 00:20
only prescribed pharmaceuticals for pain like nonsteroidal anti inflammatories and
00:21 - 00:25
opioids, medical professionals and patients are looking to cannabinoids to
00:25 - 00:26
manage chronic pain.
00:27 - 00:30
As of October 2020 the TJ is approved more than
00:31 - 00:33
72,000 medical cannabis applications.
00:34 - 00:37
Private sector data suggests that up to 80% of that
00:37 - 00:38
could relate to pain presentations.
00:40 - 00:42
So let's jump into this topic starting with the Indo
00:42 - 00:42
cannabinoid system.
00:43 - 00:45
We'll look at this integral body system before we assess
00:46 - 00:48
how we can target it to optimize chronic pain management.
00:50 - 00:55
Cannabinoid receptor Canavan Hide researcher Professor Vince Enzo de Marzo
00:56 - 00:59
summarizes the Indo cannabinoid system in five words.
00:59 - 01:03
Eat, sleep, relax, forget and protect.
01:04 - 01:07
The end of cannabinoid system, or CCS, is present in
01:07 - 01:10
all vertebrate animals and is an integral regulator in home
01:10 - 01:11
yo Stasis throughout the body.
01:13 - 01:17
The CS begins establishing from 14 weeks gestation in humans
01:18 - 01:20
and is essential in the initial formation of neuronal connectivity.
01:21 - 01:25
In general, it has influence over the activity of digestive
01:26 - 01:30
and endocrine hormones, the immune and nervous systems the body
01:31 - 01:34
produces. Endogenous cannabinoids that interact with this system and exogenous
01:35 - 01:37
cannabinoids from cannabis also have potent actions.
01:38 - 01:40
Yet it might surprise you to know there are a
01:40 - 01:43
number of other herbs that have Canada Memet IQ qualities
01:44 - 01:45
or otherwise interact with the E.
01:45 - 01:49
C s al calamities in the echinacea species interact directly
01:50 - 01:50
with the E.
01:50 - 01:54
C s fire cannabinoid receptors one and two, which may
01:54 - 01:58
have implications for inflammatory conditions and immune function by mediating
01:58 - 02:02
actions of intelligence and Truman of courses Factor Alfa.
02:04 - 02:05
There are a number of other plants that are agonist
02:06 - 02:10
for PCs, receptors or impact enzymatic processes in the system.
02:10 - 02:13
But for now, let's move on to components of the
02:13 - 02:14
entire cannabinoid system.
02:16 - 02:18
I won't spend long here, but I felt this is
02:18 - 02:20
a great example of the complexities of the under cannabinoid
02:20 - 02:25
system. This image shows the reactions between cannabinoids, receptors, enzymes
02:26 - 02:27
and a whole range of other processes in a single
02:28 - 02:31
cell. While this is an artist interpretation, it's largely biologically
02:32 - 02:35
accurate and gives an understanding of the huge influence of
02:35 - 02:36
the CS and its components.
02:37 - 02:40
Given I've already mentioned receptors, let's stop there.
02:42 - 02:43
The two key ones in the E.
02:43 - 02:46
C s a G protein coupled receptors, namely cannabinoid receptors,
02:47 - 02:48
C B one and C B two.
02:49 - 02:51
There are a number of other part G protein receptors
02:52 - 02:54
that play a role, but that's outside of today's scope.
02:55 - 02:58
Both receptors have found systemically in the body.
02:58 - 03:00
They have different areas of density if you like.
03:01 - 03:04
CB one receptors are abundant in the brain and nervous
03:04 - 03:08
system, and ah, primarily famous for their interactions with Delta.
03:09 - 03:13
Nine th see Facilitating the intoxicating effects of cannabis CB
03:13 - 03:16
one receptors contribute to maintaining home your Stasis via processes
03:17 - 03:18
in the nervous and endocrine system.
03:19 - 03:23
In influencing serotonin, dopamine and HP a access pathways, they
03:23 - 03:26
have both the direct and indirect role in mood, sleep,
03:27 - 03:28
stress, pain and more.
03:30 - 03:32
CB one receptors are found in the cardiovascular and digestive
03:33 - 03:34
systems in the heart.
03:34 - 03:38
CB one receptors more moderate dilation and contraction and vessels
03:39 - 03:40
thereby maintaining blood pressure.
03:40 - 03:43
And in the gastrointestinal tract, they have influence over appetite
03:44 - 03:45
hormones, motility and digestive secretions.
03:47 - 03:51
CB two receptors do not market modulate You forgot intoxicating
03:52 - 03:54
effects. But they do have a strong presence in the
03:54 - 03:58
immune and reproductive systems, their key mediators in the regulation
03:58 - 04:01
of inflammation, pain and the integrity nervous system, while in
04:01 - 04:05
the skeletal system they modulate bone density through supporting osteoblasts
04:06 - 04:06
and osteoclasts.
04:07 - 04:07
O Genesis.
04:08 - 04:10
There are a number of other receptors that act in
04:10 - 04:11
this CCS symphony.
04:11 - 04:12
Get only a few more.
04:12 - 04:15
Get our honorary mention here and that it's serotonin receptors.
04:16 - 04:18
Tr P V s and P p a r S
04:19 - 04:22
T L P V one receptor accounts for the mechanistic
04:23 - 04:27
action of Indo Cannabinoids and CBD and pain presentations in
04:27 - 04:29
part and P P.
04:29 - 04:32
A. Receptors are thought to play roles in both inflammation
04:33 - 04:38
Neuro protection whilst five ht three receptor activation by Ananda
04:38 - 04:44
Meid results in analgesia, the next component of the Indo
04:44 - 04:47
cannabinoids, the two most abundant and well researched and oh
04:47 - 04:49
cannabinoids are Ananda Mydd and to a rack.
04:49 - 04:52
O'Donnell, Glycerol or to a G to E.
04:52 - 04:55
J. Has a high affinity for both receptors, with basil
04:55 - 04:59
levels approximately 1000 times higher than Ananta Mind, which has
04:59 - 05:02
a lower affinity for CB one receptors in an even
05:02 - 05:06
lower affinity for C B two to age is thought
05:06 - 05:08
to have rain over the brain and nervous system while
05:09 - 05:11
in an demise influences spread more systemically.
05:12 - 05:14
There are a number of other inter cannabinoids, such as
05:15 - 05:18
P E A and N a d A, both of
05:18 - 05:22
which have relevance to pain processes and inflammation.
05:25 - 05:27
The final component of the CS for today.
05:27 - 05:31
The enzymes involved in regulating its function n a p
05:31 - 05:32
e is the synthesizing enzyme.
05:33 - 05:34
Fernanda Mydd and P I.
05:35 - 05:39
P two enzymes build to a G fatty acid, amino
05:40 - 05:46
hydrolyzed and moderate pays of the primary Who were the
05:46 - 05:54
primary? Oh fatty acid and Maynor Hydra lays and monitor
05:54 - 05:57
Astle glycerol lie pays at the primary enzymes in the
05:57 - 05:59
breakdown of an anti mine into a G respectively.
06:00 - 06:03
Though there are other metabolic pathways in which they integrated
06:04 - 06:06
Now that we have a bit of an understanding of
06:06 - 06:06
the E.
06:06 - 06:07
C s.
06:07 - 06:14
Let's look at cannabinoids seen here in light green is
06:14 - 06:17
Delta nine th see the most commonly talked about cannabinoid,
06:18 - 06:22
preclinical and animal trials show it to have analgesic, anti
06:22 - 06:25
inflammatory and anti a medic action on top of its
06:25 - 06:29
infamous youf orient or intoxicating effects, CBD is most well
06:29 - 06:32
known for its anti left, anti epileptic and anti convulsant
06:33 - 06:35
action. However, it's also known to have an algae sick
06:36 - 06:41
politic antipsychotic, antioxidant, anti spasmodic, important anti inflammatory actions.
06:42 - 06:44
I'd like to make it an important right here on
06:44 - 06:45
psycho activity.
06:46 - 06:48
I find this time is often mislabeled in the academic
06:48 - 06:51
and medical community alike, with most sources stating CBT to
06:52 - 06:52
be non psychoactive.
06:53 - 06:54
This is, in fact, a misrepresentation.
06:56 - 06:59
Psycho activity determines the substance has an action on hormones
07:00 - 07:03
or nervous system, signaling that influences cognition, mood or behaviors.
07:05 - 07:08
Given CBD has an excellent qualities attributed in part to
07:09 - 07:10
its influence over serotonin pathways.
07:11 - 07:13
It and other cannabinoids should truly be labeled psychoactive.
07:14 - 07:17
However, unlike Delta nine th c and a few others,
07:18 - 07:18
they are non intoxicating.
07:21 - 07:23
Moving on there are over 100 cannabinoids.
07:24 - 07:26
Some others include T H C A and C B
07:26 - 07:27
D A.
07:27 - 07:30
The Pacific precursors, for which all others T H C
07:30 - 07:32
and C B D type compounds are derived.
07:33 - 07:37
Minor cannabinoids with potential energetic action include C B D,
07:37 - 07:39
A, C B, C, C, B G, Delta 80 HC,
07:40 - 07:43
Delta, T, H, C V and the recently discovered T
07:43 - 07:44
H C P.
07:45 - 07:46
You'll also see Turpin's here.
07:47 - 07:52
Turbines are important features in medical cannabis formulations, so it
07:52 - 07:54
means like Huma Lane beta carry off.
07:54 - 07:59
Elaine MasseyEn have analgesic and anti inflammatory actions that can
07:59 - 08:00
contribute to pain relief.
08:01 - 08:05
Together, Cannabinoids, Turpin's and other photo chemicals engage in a
08:05 - 08:08
phenomenon known as the entourage effect, whereby cannabinoids accent logistically
08:09 - 08:12
with one another to create greater or different effects than
08:12 - 08:13
they would in isolation.
08:15 - 08:18
For Marco Kinetics of cannabinoids air vary depending on the
08:18 - 08:18
route of administration.
08:20 - 08:24
Medical cannabis can come in capsules, oils, sublingual, sprays, patches,
08:25 - 08:28
dissolvable wafers, rectal suppositories and more.
08:29 - 08:33
The traditional inhalation offers the most optimal.
08:33 - 08:36
Bio availability, however, comes with obvious risks.
08:37 - 08:40
Thus Orel and sublingual applications of the most commonly utilized
08:41 - 08:45
in practice, Orel and Sublingual bio availability ranges from 2
08:45 - 08:46
to 14%.
08:47 - 08:48
Mucosal absorption in the mouth limits.
08:49 - 08:52
First possible metabolism in this case and therefore improved by
08:52 - 08:58
availability compared to gastrointestinal absorption inhalation by smoking and vaporization
08:59 - 09:01
offers 10 to 35% of our availability.
09:02 - 09:06
Transdermal applications are difficult to measure, but CBD seems to
09:06 - 09:08
have a tenfold high absorption through the skin.
09:09 - 09:12
The th see off the Malik administration between four and
09:12 - 09:18
60% and rectal, approximately 13% in general, with cannabinoids by
09:18 - 09:21
availability, can be quite erratic and subject to into individual
09:21 - 09:26
variations, especially when comparing cannabis naive individuals to experience users.
09:27 - 09:30
The lipo flicked nature of cannabinoids mobile why they distributed,
09:30 - 09:34
and vascular rised tissue, including the heart, lungs, spleen, kidney
09:34 - 09:38
muscles and at a post tissue onset of action, peak
09:38 - 09:42
plasma levels and duration of therapeutic effect differ greatly depending
09:42 - 09:43
on the route of administration.
09:45 - 09:48
Cannabinoids metabolized primarily by C Y P 4 50 enzymes
09:49 - 09:50
for T H C.
09:50 - 09:53
That is predominantly C Y P tune C nine to
09:53 - 09:56
C 19 and 384 for C B D.
09:56 - 09:59
C Y P three a four to C 19 of
09:59 - 10:02
the main ones and in terms of elimination, cannabinoids of
10:02 - 10:06
primarily excreted through the feces but also, uh, a smaller
10:06 - 10:07
met through the urine.
10:08 - 10:10
So what does the research say about medical cannabis for
10:11 - 10:12
pain? The evidence is promising.
10:13 - 10:15
All those still mixed enoughto warrant further investigations.
10:17 - 10:20
This is attributed to varied photochemical profiles endorsing of formulations,
10:21 - 10:24
a ZX well as differences in types of pain that
10:24 - 10:29
have been investigated in the 2018 try, A 177 patients
10:30 - 10:34
with treatment resistant cancer pain, 43% showed a 30% reduction
10:35 - 10:38
in pain scores, while 30% may not seem large in
10:38 - 10:41
terms of chronic pain management, it is clinically significant value.
10:42 - 10:46
A small study of fibromyalgia patients reported 50% to be
10:46 - 10:48
able to cease their pain medications.
10:49 - 10:51
And there's plenty of supporting evidence for medical cannabis in
10:51 - 10:54
pain and inflammation that's associated with arthritic conditions.
10:56 - 10:59
In terms of CBD, solid amounts of human clinical data
10:59 - 11:02
is still lacking, although it seems to be effective, especially
11:03 - 11:03
neuropathic pain.
11:04 - 11:08
UH, numerous examples for CBD to be more effective and
11:08 - 11:11
algae sick when combined with even small amounts of th
11:11 - 11:12
C or other cannabinoids.
11:14 - 11:16
There are also a number of systematic reviews and meta
11:16 - 11:22
analysis concluding, uh, cannabinoids may provide effective pain relief, especially
11:22 - 11:23
in difficult to treat instances.
11:26 - 11:29
There are dozens of farmer co dynamic mechanisms can happen
11:29 - 11:31
whites, but specifically in relation to pain.
11:31 - 11:34
The analgesic action of th C is attributed to it
11:34 - 11:37
binding with CB one receptors prevalent along pain pathways in
11:37 - 11:40
the CNS, where it has an inhibitory effect on calcium
11:41 - 11:43
ion channels and therefore neurotransmitter availability.
11:45 - 11:49
CBD has an algae zik action being associated with its
11:49 - 11:52
agonists. Agon is, um of T R P v 15
11:53 - 11:55
ht three and five ht.
11:55 - 11:55
One A.
11:55 - 12:01
Receptors. It's acidic form CBD a selectively inhibits cox two
12:01 - 12:04
and therefore inflammatory prostaglandin production in a similar fashion thio
12:05 - 12:09
nonsteroidal anti inflammatories, which give it a huge potential for
12:09 - 12:15
replacing or augmenting other pain medications as within any drug
12:15 - 12:17
or medicine, there are potential side effects.
12:18 - 12:19
T H C is well known.
12:20 - 12:23
Side effects that include euphoria and paranoia are the so
12:24 - 12:26
called side effects that can also be used to therapeutic
12:26 - 12:31
benefit. Include appetite, stimulation, sedation on increased memory loss.
12:32 - 12:36
The letter has a huge relevance for PTSD sufferers re
12:36 - 12:38
experiencing traumatic events.
12:40 - 12:43
Side effects of CBD include drowsiness, gastrointestinal upset and nausea.
12:44 - 12:48
While patients report these generally to be tolerable, a personalized
12:49 - 12:52
medicine approach with slow tied direction generally mitigates the manifestation
12:53 - 12:57
of most side effects in terms of interactions, drugs or
12:57 - 12:59
substances that are processed by C Y.
12:59 - 13:00
P. 4 50 enzymes.
13:01 - 13:07
Uh uh, In terms of interactions, drugs or substances that
13:07 - 13:10
are processed by C Y P for 50 enzymes have
13:10 - 13:14
the potential to interact with cannabinoid medicines, especially given the
13:14 - 13:16
involvement of C Y P three a four.
13:16 - 13:20
In more than 60% of pharmaceutical drug metabolism, cannabinoids, especially
13:20 - 13:23
CBD, have the potential to enhance or inhibit their metabolism.
13:24 - 13:28
C Y p 4 50 Cautions of general in relation
13:28 - 13:30
to medical cannabis and have yet to be correlated in
13:30 - 13:31
human trials.
13:32 - 13:37
Cannabinoids have the ability to both enhance and synergistically act
13:37 - 13:38
with opioid medications.
13:39 - 13:44
Teetsi particularly has the potential Azan opioid sparing action.
13:47 - 13:50
They have bean proven interactions with one epilepsy drug clubbers
13:51 - 13:54
um, and some research showing liver enzyme changes in Children
13:55 - 13:56
administered CBD again.
13:57 - 14:00
Careful tight rationing, ongoing monitoring as with any drug to
14:00 - 14:09
avoid negative interactions on dhe adverse effects moving forward.
14:09 - 14:13
Prominent cannabinoid researcher Ethan Russo and other thought leaders in
14:13 - 14:16
the scientific community theorized that many difficult to treat and
14:17 - 14:21
otherwise idiopathic conditions may be related to deficiency or dysfunction.
14:21 - 14:22
In the e.
14:22 - 14:29
C. S in Dimitrios is fibromyalgia multiple sclerosis, PB, Parkinson's
14:29 - 14:32
disease. You're gonna make me do it again
See full transcript